The Disruptive Power of Pharma AI
In the first of the Pharma Integrates Insights series, Marco Mohwinckel examines the adoption of artificial intelligence (AI) by pharmaceutical companies and sheds some light on what’s real … and what’s yet to come
Revolutionising Drug Discovery with Big Data and AI
As terabytes of healthcare data are generated that are more easily accessible to a broader range of stakeholders, Marco Mohwinckel examines whether a new age of AI-driven drug discovery is just around the corner
Award-winning innovation partner for #medicines development @CatSciLtd is furthering its strategic expansion with a strengthened Senior #Leadership Team. These industry-renowned experts bring decades of experience across the CMC landscape
https://www.lifescienceintegrates.com/cardiff-based-catsci-strengthens-senior-leadership-team-with-series-of-a-notable-appointments/
Coming up in November, #PharmaIntegrates is the must-attend events for leaders & innovators across the #pharma & #healthcare sector looking to revolutionise modern #medicine.
Covering Big Health, Technology & Industry Enablers, get your ticket now:
https://www.lifescienceintegrates.com/event/pharma-integrates-2022/
Next in our #AdvancedTherapiesIntegrates Q&A series is Ian Anderson, Global Sr Principal Scientist, Global Biologics, @LonzaGroup
With 10+ years industrial CMC experience, you won’t want to miss Ian’s answers:
https://www.lifescienceintegrates.com/3-questions-with-ian-anderson/
#AdvancedTherapies #CellandGene #ATMPs